FDA Import Refusal AEK-2117325-6/60003/1 — Cadila Pharmaceuticals Limited
The FDA refused shipment AEK-2117325-6/60003/1 from Cadila Pharmaceuticals Limited (India) on Sep 18, 2026. The refused product falls under Drugs and Biologics — ERGOTAMINE TARTRATE (ANALGESIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 18, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60LCY80 ERGOTAMINE TARTRATE (ANALGESIC)
- Charges
- 75